LivaNova launches international pivotal study evaluating autonomic regulation therapy
LivaNova announced the first successful implantation of the VITARIA® System in a patient enrolled in the Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure With Reduced Ejection Fraction Pivotal Study. September 18, 2018